KAT8 and colorectal carcinoma: The KAT8-specific inhibitor MG149 weakens eEF1A2 lactylation, inhibits CRC proliferation and metastasis, and exerts synergistic effects when combined with 5-fluorouracil chemotherapy (Xie et al., 2024).